November 13, 2026
$RichWire Markets and money, explained simply
LIVE
Birchtech Shares Climb 6% on Strategic Pivot and Litigation Progress Fractyl Health Cuts 45% of Staff to Pursue Commercial Launch for Weight-Loss System Inuvo Pivots Away From Legacy Search to Focus Entirely on AI Audience Modeling Motorsport Games Reports Q3 2026 Financial Results Nvidia Faces High Expectations Ahead of Fiscal Q3 2027 Results United States Antimony Posts Revenue Growth Amid Shifting Sales Strategy GCT Semiconductor Reports Revenue Growth but Delays 5G Volume Ramp to 2027 Intuitive Machines Posts Record $269 Million Revenue on Expanding Space Operations Minerva Neurosciences Highlights Progress on Schizophrenia Treatment InspireMD Hosts Third Quarter 2026 Earnings Call Describing Financial Performance Jane Street Doubles Nvidia Stake Before Executive Scandal Erases Value Comparing U.S. Bank Sector ETFs: State Street's KBE vs. First Trust's FTXO Birchtech Shares Climb 6% on Strategic Pivot and Litigation Progress Fractyl Health Cuts 45% of Staff to Pursue Commercial Launch for Weight-Loss System Inuvo Pivots Away From Legacy Search to Focus Entirely on AI Audience Modeling Motorsport Games Reports Q3 2026 Financial Results Nvidia Faces High Expectations Ahead of Fiscal Q3 2027 Results United States Antimony Posts Revenue Growth Amid Shifting Sales Strategy GCT Semiconductor Reports Revenue Growth but Delays 5G Volume Ramp to 2027 Intuitive Machines Posts Record $269 Million Revenue on Expanding Space Operations Minerva Neurosciences Highlights Progress on Schizophrenia Treatment InspireMD Hosts Third Quarter 2026 Earnings Call Describing Financial Performance Jane Street Doubles Nvidia Stake Before Executive Scandal Erases Value Comparing U.S. Bank Sector ETFs: State Street's KBE vs. First Trust's FTXO

InspireMD Hosts Third Quarter 2026 Earnings Call Describing Financial Performance

🧠 AI Analysis 1 min read 👁 0

InspireMD executives reviewed the company's financial results and forward-looking expectations during their third-quarter 2026 earnings conference call.

InspireMD Hosts Third Quarter 2026 Earnings Call Describing Financial Performance🧠AI Analysis

Photo: Seeking Alpha

Key points

  • InspireMD held its Q3 2026 earnings call on November 12, 2026.
  • CEO Marvin Slosman and CFO Michael Lawless led the management discussion.
  • Executives highlighted standard forward-looking risk disclosures and SEC filing references.

Medical device maker InspireMD, Inc. held its third-quarter 2026 earnings conference call on November 12, 2026, providing investors with an overview of the company's recent operational and financial performance. Leadership members, including President and Chief Executive Officer Marvin Slosman and Chief Financial Officer Michael Lawless, addressed analysts during the event.

The discussion opened with introductory remarks from Alexandra Grossman of LifeSci Advisors, followed by standard cautionary notices regarding forward-looking statements. Management reminded participants that operational projections carry inherent uncertainties and directed stakeholders to SEC filings and official press releases for comprehensive risk disclosures.

What to watch next: Investors will be tracking upcoming regulatory updates and subsequent quarterly filings to gauge the firm's commercial execution.

Source Seeking Alpha — seekingalpha.com/article/4967397-inspiremd-inc-nspr-q3-2026-earnings-ca… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.